IBIO iBio, Inc.

NYSE ibioinc.com


$ 1.61 $ 0.00 (0 %)    

Thursday, 23-Oct-2025 06:17:09 EDT
QQQ $ 605.91 $ 0.00 (0 %)
DIA $ 465.43 $ 0.00 (0 %)
SPY $ 668.20 $ 0.00 (0 %)
TLT $ 91.51 $ 0.00 (0 %)
GLD $ 378.94 $ 0.00 (0 %)
$ 1.39
$ 1.02
$ 1.59 x 1
$ 1.62 x 9
-- - --
$ 0.56 - $ 6.89
26,729,257
na
27.32M
$ 1.16
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-05-2025 06-30-2025 10-K
2 05-02-2025 03-31-2025 10-Q
3 02-10-2025 12-31-2024 10-Q
4 11-12-2024 09-30-2024 10-Q
5 09-20-2024 06-30-2024 10-K
6 05-13-2024 03-31-2024 10-Q
7 02-09-2024 12-31-2023 10-Q
8 11-14-2023 09-30-2023 10-Q
9 09-27-2023 06-30-2023 10-K
10 05-15-2023 03-31-2023 10-Q
11 02-14-2023 12-31-2022 10-Q
12 11-14-2022 09-30-2022 10-Q
13 10-11-2022 06-30-2022 10-K
14 05-12-2022 03-31-2022 10-Q
15 02-14-2022 12-31-2021 10-Q
16 11-15-2021 09-30-2021 10-Q
17 09-28-2021 06-30-2021 10-K
18 05-17-2021 03-31-2021 10-Q
19 02-16-2021 12-31-2020 10-Q
20 11-16-2020 09-30-2020 10-Q
21 10-13-2020 06-30-2020 10-K
22 05-15-2020 03-31-2020 10-Q
23 02-14-2020 12-31-2019 10-Q
24 11-14-2019 09-30-2019 10-Q
25 08-26-2019 06-30-2019 10-K
26 05-10-2019 03-31-2019 10-Q
27 02-13-2019 12-31-2018 10-Q
28 11-13-2018 09-30-2018 10-Q
29 09-18-2018 06-30-2018 10-K
30 05-11-2018 03-31-2018 10-Q
31 02-14-2018 12-31-2017 10-Q
32 11-09-2017 09-30-2017 10-Q
33 09-15-2017 06-30-2017 10-K
34 05-15-2017 03-31-2017 10-Q
35 02-21-2017 12-31-2016 10-Q
36 11-18-2016 09-30-2016 10-Q
37 10-13-2016 06-30-2016 10-K
38 05-23-2016 03-31-2016 10-Q
39 02-22-2016 12-31-2015 10-Q
40 11-13-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-did-ibio-shares-surge-over-11-in-pre-market-trading

iBio shares rose sharply after announcing upcoming presentations on its obesity treatment candidate at two industry conferences.

 oppenheimer-initiates-coverage-on-ibio-with-outperform-rating-announces-price-target-of-5

Oppenheimer analyst Jay Olson initiates coverage on iBio (NASDAQ:IBIO) with a Outperform rating and announces Price Target o...

 leerink-partners-initiates-coverage-on-ibio-with-outperform-rating-announces-price-target-of-2

Leerink Partners analyst Roanna Ruiz initiates coverage on iBio (NASDAQ:IBIO) with a Outperform rating and announces Price T...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION